ERT has snatched up iCardiac Technologies, which pioneered precision QT studies in early-phase clinical research.
X-Chem will screen its DNA-encoded libraries to discover novel antivirals for Gilead.
HitGen has formed a drug discovery research collaboration with Boehringer Ingelheim to identify novel small-molecule leads.
Quotient Clinical has rebranded as Quotient Sciences, and right after that, made its third purchase this year.
Aquila BioMedical signed an extended contract with Macrophage Pharma to support its preclinical immuno-oncology programs.
Bioclinica is looking to broaden its reach with the purchase of MDDX Research & Informatics.
Imricor Medical Systems and Mirtle Medical are combining their offerings to create an alternative to x-ray guided ablation.
Major CRO player PPD has won a lucrative seven-year government contract in infectious disease.
Clinerion inks a new deal that adds 60 million U.S. patients to its clinical trial patient recruitment system.
Medical devices-focused CRO Factory has expanded in North America with the acquisition of Milestone.